Both in Pharmaceuticals
ARS Pharmaceuticals vs Fulcrum Therapeutics
Over the past year SPRY returned −65.0% and FULC returned −55.0%; their daily moves had a correlation of 0.14.
SPRY −65.0% FULC −55.0%Growth of $1, one year, split-adjusted
| Metric | SPRY | FULC |
|---|---|---|
| Price | $3.05 | $3.77 |
| Market cap | $303.3M | $288.0M |
| Today | 0.00% | +0.80% |
| 1 month | −29.0% | +2.2% |
| 6 months | −67.1% | −47.0% |
| Year to date | −73.8% | −66.7% |
| 1 year | −64.6% | −58.2% |
| Revenue growth (YoY) | +114.2% | — |
| Gross margin | 61.8% | — |
| Net margin | −185.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.6× | — |
| Net cash | -$27.8M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 69.9% | 15.0% |
| Short % of float | 40.5% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).